Identification and optimisation of 4, 5-dihydrobenzo[1, 2-d:3, 4-d]bisthiazole and 4, 5-dihydrothiazolo[4, 5-h]quinazoline series of selective phosphatidylinositol-3 kinase alpha inhibitors. Issue 17 (1st September 2015)